CTVA Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

4.24B

+6.52%

0.213

-33.46%

4.64B

+4.99%

1.166

+3.17%

6.73B

+4.26%

2.311

+5.07%

Estimates Revision

The market is revising Upward the revenue expectations for Corteva, Inc. (CTVA) for FY2025, with the revenue forecasts being adjusted by 0.72% over the past three months. During the same period, the stock price has changed by -5.72%.

Revenue Estimates for FY2025

Revise Upward

+0.72%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+6.58%

In Past 3 Month

Stock Price

Go Down

-5.72%

In Past 3 Month

17 Analyst Rating

Wall Street analysts forecast CTVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CTVA is 78.31 USD with a low forecast of 67.00 USD and a high forecast of 86.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

14 Buy

3 Hold

0 Sell

Strong Buy

Current: 65.880

Low

67.00

Averages

78.31

High

86.00

Current: 65.880

Low

67.00

Averages

78.31

High

86.00

Wells Fargo

Overweight

downgrade

$80 -> $77

2025-11-11

Reason

Wells Fargo

Price Target

$80 -> $77

2025-11-11

downgrade

Overweight

Reason

Wells Fargo assumed coverage of Corteva with an Overweight rating with a price target of $77, down from $80. The firm continues to believe in Corteva's ability to innovate and drive earnings growth, even as two separate companies.

Oppenheimer

Outperform

maintain

$75 -> $76

2025-11-07

Reason

Oppenheimer

Price Target

$75 -> $76

2025-11-07

maintain

Outperform

Reason

Oppenheimer raised the firm's price target on Corteva to $76 from $75 and keeps an Outperform rating on the shares. The firm remains constructive on shares of Corteva following a strong Q3 reminding investors why it has historically garnered a quality premium. Despite continued end-market challenges, the company delivered another beat-and-raise on strong volumes, execution against controllables, and comparatively dampened price pressures, Oppenheimer adds.

UBS

Buy

downgrade

$85 -> $81

2025-10-30

Reason

UBS

Price Target

$85 -> $81

2025-10-30

downgrade

Buy

Reason

UBS lowered the firm's price target on Corteva to $81 from $85 and keeps a Buy rating on the shares.

Wells Fargo

Overweight

downgrade

$83 -> $80

2025-10-16

Reason

Wells Fargo

Price Target

$83 -> $80

2025-10-16

downgrade

Overweight

Reason

Wells Fargo lowered the firm's price target on Corteva to $80 from $83 and keeps an Overweight rating on the shares. The firm adjusts its Q3 estimates ahead of results as our checks point to softening demand and sentiment throughout the quarter on rising concerns about 2026, given this year's expected record harvest. Wells expects a more cautious outlook tone with Q3 results.

BofA

Buy

maintain

$79

2025-09-15

Reason

BofA

Price Target

$79

2025-09-15

maintain

Buy

Reason

After The Wall Street Journal reported that Corteva is exploring the separation of its seed and crop chemical franchises, BofA said that the integrated seed/CP model is the "gold standard" in crop inputs given the highly synergistic nature and contends that this is more relevant as biologics and seed treatment technologies proliferate. Given this view, the firm does not see the financial or strategic merits of a potential break-up, the analyst tells investors. In addition, the current valuation doesn't show immediate value creation through a sum-of-the-parts analysis and the firm believes that any separation would "possibly create two weaker entities," says the analyst, who has a Buy rating and $79 price target on Corteva shares.

Oppenheimer

Outperform

maintain

$87

2025-09-15

Reason

Oppenheimer

Price Target

$87

2025-09-15

maintain

Outperform

Reason

Oppenheimer maintains the firm's bullish stance on Corteva (CTVA) following media reports Friday of a potential Seed/CP split. While unconfirmed, the stock closed about 2% higher on the news. Strategically, the firm believes one of Corteva's leading competitive advantages is its integrated Seed plus CP R&D capabilities enabling blockbusters like the Enlist system. These advantages must be weighed against the crosswinds of a dynamic regulatory backdrop, and clear sum-of-the-parts discount attributable to the Crop Protection business, Oppenheimer adds. Moreover, with the potential for both BASF (BASFY) and Bayer (BAYRY) to spin out their Ag businesses as independent companies, the firm sees a potential split of Corteva altering the calculus for how peers choose to align their own deconsolidation. Oppenheimer has an Outperform rating on Corteva's shares with a price target of $87.

Valuation Metrics

The current forward P/E ratio for Corteva Inc (CTVA.N) is 19.43, compared to its 5-year average forward P/E of 20.16. For a more detailed relative valuation and DCF analysis to assess Corteva Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

20.16

Current PE

19.43

Overvalued PE

22.25

Undervalued PE

18.07

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

11.95

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

13.06

Undervalued EV/EBITDA

10.85

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

2.27

Current PS

0.00

Overvalued PS

2.51

Undervalued PS

2.03

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

CTVA News & Events

Events Timeline

No data

News

8.0

12-09Barron's

Nvidia's Huang Achieves Success with Trump: Insights for Netflix and Paramount.

8.0

12-08Barron's

Trump to Provide $12 Billion to Farmers: Stocks That May Benefit and Those That Won't.

8.0

11-28NASDAQ.COM

Upcoming Ex-Dividend Dates for Advanced Drainage Systems, Corteva, and Boise Cascade

People Also Watch

Frequently Asked Questions

What is Corteva Inc (CTVA) stock price today?

The current price of CTVA is 65.88 USD — it has decreased -0.36 % in the last trading day.

What is Corteva Inc (CTVA)'s business?

Corteva, Inc. is a global pure-play agriculture company. It is a global provider of seed and crop protection solutions focused on the agriculture industry and contributing to a healthier, secure and sustainable food supply. The Seed segment is engaged in developing and supplying commercial seed combining advanced germplasm and traits that produce optimum yield for farms around the world. It operates in various key seed markets, including North American corn and soybeans, European corn and sunflower, as well as Brazil, India, South Africa and Argentina corn. The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that support overall crop health both above and below ground via nitrogen management and seed-applied technologies. Its crop protection solutions and digital solutions provide farmers with tools to improve productivity and help keep fields free of weeds, insects and diseases.

What is the price predicton of CTVA Stock?

What is Corteva Inc (CTVA)'s revenue for the last quarter?

Corteva Inc revenue for the last quarter amounts to 2.62B USD, increased 12.55 % YoY.

What is Corteva Inc (CTVA)'s earnings per share (EPS) for the last quarter?

Corteva Inc. EPS for the last quarter amounts to -0.47 USD, decreased -38.16 % YoY.

What changes have occurred in the market's expectations for Corteva Inc (CTVA)'s fundamentals?

How many employees does Corteva Inc (CTVA). have?

Corteva Inc (CTVA) has 22000 emplpoyees as of December 16 2025.

What is Corteva Inc (CTVA) market cap?

Today CTVA has the market capitalization of 44.52B USD.